A molecular process caused by the TREM2 gene mutation in the brain's microglia increases the risk of Alzheimer's disease, a new study reports.
Testing for specific inflammatory proteins in cerebrospinal fluid can help doctors to diagnose the early onset of Alzheimer's disease and track the progression of the disease in patients.
DHA treatment reduced the size of the damaged brain area and initiated a repair mechanism in animal models of stroke. DHA affected the levels of MANF and TREM2, two proteins critical for communication between brain cells.
Researchers uncover a second rare genetic mutation which increases the risk of developing Alzheimer's disease later in life.
According to a new study, triggering TREM2 could help slow the progression of some neurodegenerative diseases.
A new study investigates how genetics risk factors for Alzheimer's could influence a key immune cell.
Rapamycin, a drug approved for the treatment of cancer and transplant patients increases amyloid-beta protein plaques in the brains of mice.